What is the ticker symbol for ALX Oncology?

ALX Oncology trades under the ticker ALXO on NASDAQ.

What sector does ALX Oncology operate in?

ALX Oncology is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ALXO in a portfolio?

PortView shows ALXO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

ALX Oncology (ALXO) Stock Analysis

NASDAQHealthcareBiotechnology

$2.04+2.78%

1-year price historyRange $1.02 – $2.60

52-week range$2.04

$0.96$2.66

What ALX Oncology does

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company’s lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic development as a combination therapy with other anti-cancer agents, including ASPEN-06, under phase 2 clinical study for treating Gastric/GEJ cancer. It has collaboration agreement for Evorpacept combination programs comprising Jazz Pharmaceuticals plc for zanidatamab, under phase 1b/2 trial for the treatment of breast cancer and other solid tumors; HER2 with an ADC, fam-trastuzumab deruxtecan-nxki, under phase 1 trial for the treatment of patients with breast cancer; ALX2004, under phase 1 clinical trial for treating solid tumors; MD Anderson Cancer Center with rituximab and lenalidomide for the treatment of patients with indolent and aggressive NHL; and Sanofi with isatuximab and dexamethasone, under phase 1/2 trial for the treatment of patients with relapsed or refractory multiple myeloma. It has license agreements with Board of Trustees of Leland Stanford Junior University. The company was incorporated in 2015 and is headquartered in South San Francisco, California.

Key metrics

Market cap

$273.84M

P/E (TTM)

-1.80

EPS (TTM)

$-1.13

Beta

0.40

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.02

200-day avg

$1.81

52-week high

$2.66

52-week low

$0.96

CEO

Jason Lettmann

ETFs linked to ALXO

Broad-market and Healthcare sector ETFs an investor holding ALX Oncology is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ALXO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ALXO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for ALX Oncology?: ALX Oncology trades under the ticker ALXO on NASDAQ.
Which exchange is ALXO listed on?: ALXO is listed on NASDAQ.
What sector does ALX Oncology operate in?: ALX Oncology is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ALXO in a portfolio?: PortView shows ALXO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.